The Oncology Institute, Inc.
TOI
$3.31
$0.082.48%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 29.71% | 7.50% | 8.39% | 33.70% | -70.38% |
| Total Depreciation and Amortization | 8.24% | -7.36% | 14.22% | 17.34% | 32.30% |
| Total Amortization of Deferred Charges | 1.40% | 1.34% | 1.36% | 2.36% | 1.29% |
| Total Other Non-Cash Items | -74.69% | -66.81% | -96.01% | -77.68% | 1,120.54% |
| Change in Net Operating Assets | 97.55% | 1,131.77% | -289.12% | 42.81% | 223.53% |
| Cash from Operations | 207.53% | 109.86% | -80.83% | -2.79% | 72.19% |
| Capital Expenditure | -103.83% | 143.23% | -94.88% | 66.83% | 56.84% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | 66.81% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -100.00% | 15.75% | -33.64% | -1.20% | 142.00% |
| Cash from Investing | -115.09% | 34.93% | -27.01% | 5.36% | 135.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 64.44% | -61.38% | 99.34% | 22.23% | 34.79% |
| Issuance of Common Stock | -100.00% | -100.00% | -- | -- | -74.43% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -27.65% | 61.56% | -511.43% | -- | -62.96% |
| Cash from Financing | 90.79% | 67.86% | 17.45% | 45.11% | -110.27% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -61.92% | 908.99% | -97.30% | 107.02% | 112.56% |